RHUMBLINE ADVISERS - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$1,206,000
+3.4%
107,645
+1.5%
0.00%0.0%
Q2 2017$1,166,000
+17.7%
106,035
+4.8%
0.00%
+50.0%
Q1 2017$991,000
+30.4%
101,172
+43.8%
0.00%0.0%
Q4 2016$760,000
+13.3%
70,368
+7.5%
0.00%0.0%
Q3 2016$671,000
-17.8%
65,438
+4.7%
0.00%0.0%
Q2 2016$816,000
+43.9%
62,508
+21.3%
0.00%0.0%
Q1 2016$567,000
+19.9%
51,543
+0.2%
0.00%0.0%
Q4 2015$473,000
+44.2%
51,463
+9.0%
0.00%
+100.0%
Q3 2015$328,000
-26.0%
47,228
+4.7%
0.00%0.0%
Q2 2015$443,000
-19.2%
45,092
-27.0%
0.00%
-50.0%
Q1 2015$548,000
+14.9%
61,807
+13.6%
0.00%
+100.0%
Q4 2014$477,000
+33.6%
54,407
+4.9%
0.00%0.0%
Q3 2014$357,000
+29.8%
51,862
-0.7%
0.00%0.0%
Q2 2014$275,000
+15.5%
52,212
-0.0%
0.00%0.0%
Q1 2014$238,000
-14.1%
52,232
-4.8%
0.00%0.0%
Q4 2013$277,000
-2.8%
54,862
-2.3%
0.00%0.0%
Q3 2013$285,000
+1.4%
56,162
-0.9%
0.00%0.0%
Q2 2013$281,00056,6530.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders